Amodiaquine+Artesunate for Uncomplicated Malaria Treatment
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
This is a phase IV one-arm study aiming at recruiting 50 patients to assess the efficacy of
AQ+AS in patients with a positive RDT diagnosis of malaria in Nanoro, Burkina Faso.
Phase:
Phase 4
Details
Lead Sponsor:
Centre Muraz
Collaborator:
Institute of Tropical Medicine, Belgium
Treatments:
Amodiaquine Amodiaquine, artesunate drug combination Artemisinins Artesunate